However, effective identification of mutated high-risk cancer genes such as BRCA1 and BRCA2 depends on the availability of and access to genetic counseling and testing for people at high risk of a hereditary cancer syndrome. The gene discussed is BRCA2; the disease is Inherited cancer-predisposing syndrome.